Koh B Boayue

Suggest Changes
Learn More
BACKGROUND The oral thrombopoietin receptor agonist eltrombopag is approved for treatment of adults with chronic immune thrombocytopenia. In the PETIT trial, we aimed to investigate the efficacy and(More)
  • 1